Versiti Diagnostic Labs
As an esoteric reference laboratory and a leader in hematology diagnostics, Versiti Diagnostic Laboratories are proud to pioneer patient care through focused insights and solutions. Our wide range of services includes highly specialized, functional and genetic diagnostics. Our collaborative approach brings together clinical expertise and laboratory innovation, resulting in actionable solutions.
Cenetron specializes in molecular diagnostics and has supported pivotal global trials for COVID-19, HCV, HIV and HBV drug development programs.
Expertise Across the Spectrum of Blood Health
Versiti Diagnostic Labs pioneer patient care through focused insights and solutions, including highly specialized functional and genetic diagnostics for a variety of non-malignant blood disorders. Our collaborative approach brings together clinical expertise and laboratory innovation, resulting in actionable solutions for use in a trial, the clinic and the hospital.
Versiti Diagnostic Labs provide innovative diagnostic and prognostic testing in blood cancers to support patient stratification and therapeutic decisions. Versiti delivers novel testing services that provide critical clinical direction in complex cases of acute myeloid leukemia (AML), myeloproliferative neoplasms (MPN) and chronic myelogenous leukemia (CML). Testing menus are built around testing algorithms as recommended by the National Comprehensive Cancer Network (NCCN) and the World Health Organization (WHO).
Versiti counts a number of practicing physicians who have training in pathology, internal medicine and/or hematology, and blood banking and transfusion medicine. These experts are involved in medical direction for Versiti Diagnostic Labs and participate in basic science, clinical and/or applied research related to transfusion medicine and hemostasis.
Versiti Diagnostic Labs’ specialized focus in hematology includes research and diagnostic services for medical conditions like anemia, platelet and white blood cell disorders, sickle cell disease, and bleeding and clotting disorders.
Versiti’s scientific and medical leadership is globally recognized for providing advanced testing and consultation to improve patient outcomes and increase access to organ, tissue, bone marrow and stem cell transplantation. Our transplant portfolio includes:
- Testing services for histocompatibility and immunogenetics
- Infectious disease marker testing
- Post-transplant monitoring
Versiti’s state-of-the-art histocompatibility laboratories support active stem cell transplant programs by providing rapid turnaround time for histocompatibility and immunogenetics testing with value-added consultative services.